Endothelial colony-forming cells reduced the lung injury induced by cardiopulmonary bypass in rats
Background Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect of endothelial colony-forming cells (ECFCs) on lung injury in rats subjected to CPB. Methods Thirty-two rats were randomized into the sham,...
Saved in:
Published in: | Stem cell research & therapy Vol. 11; no. 1; pp. 1 - 12 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
BioMed Central Ltd
25-06-2020
BioMed Central BMC |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect of endothelial colony-forming cells (ECFCs) on lung injury in rats subjected to CPB. Methods Thirty-two rats were randomized into the sham, CPB, CPB/ECFC and CPB/ECFC/L-NIO groups. The rats in the sham group received anaesthesia, and the rats in the other groups received CPB. The rats also received PBS, ECFCs and L-NIO-pre-treated ECFCs. After 24 h of CPB, pulmonary capillary permeability, including the PaO.sub.2/FiO.sub.2 ratio, protein levels in bronchoalveolar lavage fluid (BALF) and lung tissue wet/dry weight were evaluated. The cell numbers and cytokines in BALF and peripheral blood were tested. Endothelial injury, lung histological injury and apoptosis were assessed. The oxidative stress response and apoptosis-related proteins were analysed. Results After CPB, all the data deteriorated compared with those obtained in the S group (sham vs CPB vs CPB/ECFC vs CPB/ECFC/L-NIO: histological score 1.62 [+ or -] 0.51 vs 5.37 [+ or -] 0.91 vs 3.37 [+ or -] 0.89 vs 4.37 [+ or -] 0.74; PaO.sub.2/FiO.sub.2 389 [+ or -] 12 vs 233 [+ or -] 36 vs 338 [+ or -] 28 vs 287 [+ or -] 30; wet/dry weight 3.11 [+ or -] 0.32 vs 6.71 [+ or -] 0.73 vs 4.66 [+ or -] 0.55 vs 5.52 [+ or -] 0.57; protein levels in BALF: 134 [+ or -] 22 vs 442 [+ or -] 99 vs 225 [+ or -] 41 vs 337 [+ or -] 53, all P < 0.05). Compared to the CPB treatment, ECFCs significantly improved pulmonary capillary permeability and PaO.sub.2/FiO.sub.2. Similarly, ECFCs also decreased the inflammatory cell number and pro-inflammatory factors in BALF and peripheral blood, as well as the oxidative stress response in the lung tissue. ECFCs reduced the lung histological injury score and apoptosis and regulated apoptosis-related proteins in the lung tissue. Compared with the CPB/ECFC group, all the indicators were partly reversed by the L-NIO. Conclusions ECFCs significantly reduced lung injury induced by inflammation after CPB. Keywords: Endothelial colony-forming cells, Cardiopulmonary bypass, Inflammation, Lung injury |
---|---|
AbstractList | Background Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect of endothelial colony-forming cells (ECFCs) on lung injury in rats subjected to CPB. Methods Thirty-two rats were randomized into the sham, CPB, CPB/ECFC and CPB/ECFC/L-NIO groups. The rats in the sham group received anaesthesia, and the rats in the other groups received CPB. The rats also received PBS, ECFCs and L-NIO-pre-treated ECFCs. After 24 h of CPB, pulmonary capillary permeability, including the PaO.sub.2/FiO.sub.2 ratio, protein levels in bronchoalveolar lavage fluid (BALF) and lung tissue wet/dry weight were evaluated. The cell numbers and cytokines in BALF and peripheral blood were tested. Endothelial injury, lung histological injury and apoptosis were assessed. The oxidative stress response and apoptosis-related proteins were analysed. Results After CPB, all the data deteriorated compared with those obtained in the S group (sham vs CPB vs CPB/ECFC vs CPB/ECFC/L-NIO: histological score 1.62 [+ or -] 0.51 vs 5.37 [+ or -] 0.91 vs 3.37 [+ or -] 0.89 vs 4.37 [+ or -] 0.74; PaO.sub.2/FiO.sub.2 389 [+ or -] 12 vs 233 [+ or -] 36 vs 338 [+ or -] 28 vs 287 [+ or -] 30; wet/dry weight 3.11 [+ or -] 0.32 vs 6.71 [+ or -] 0.73 vs 4.66 [+ or -] 0.55 vs 5.52 [+ or -] 0.57; protein levels in BALF: 134 [+ or -] 22 vs 442 [+ or -] 99 vs 225 [+ or -] 41 vs 337 [+ or -] 53, all P < 0.05). Compared to the CPB treatment, ECFCs significantly improved pulmonary capillary permeability and PaO.sub.2/FiO.sub.2. Similarly, ECFCs also decreased the inflammatory cell number and pro-inflammatory factors in BALF and peripheral blood, as well as the oxidative stress response in the lung tissue. ECFCs reduced the lung histological injury score and apoptosis and regulated apoptosis-related proteins in the lung tissue. Compared with the CPB/ECFC group, all the indicators were partly reversed by the L-NIO. Conclusions ECFCs significantly reduced lung injury induced by inflammation after CPB. Keywords: Endothelial colony-forming cells, Cardiopulmonary bypass, Inflammation, Lung injury Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect of endothelial colony-forming cells (ECFCs) on lung injury in rats subjected to CPB. Thirty-two rats were randomized into the sham, CPB, CPB/ECFC and CPB/ECFC/L-NIO groups. The rats in the sham group received anaesthesia, and the rats in the other groups received CPB. The rats also received PBS, ECFCs and L-NIO-pre-treated ECFCs. After 24 h of CPB, pulmonary capillary permeability, including the PaO.sub.2/FiO.sub.2 ratio, protein levels in bronchoalveolar lavage fluid (BALF) and lung tissue wet/dry weight were evaluated. The cell numbers and cytokines in BALF and peripheral blood were tested. Endothelial injury, lung histological injury and apoptosis were assessed. The oxidative stress response and apoptosis-related proteins were analysed. After CPB, all the data deteriorated compared with those obtained in the S group (sham vs CPB vs CPB/ECFC vs CPB/ECFC/L-NIO: histological score 1.62 [+ or -] 0.51 vs 5.37 [+ or -] 0.91 vs 3.37 [+ or -] 0.89 vs 4.37 [+ or -] 0.74; PaO.sub.2/FiO.sub.2 389 [+ or -] 12 vs 233 [+ or -] 36 vs 338 [+ or -] 28 vs 287 [+ or -] 30; wet/dry weight 3.11 [+ or -] 0.32 vs 6.71 [+ or -] 0.73 vs 4.66 [+ or -] 0.55 vs 5.52 [+ or -] 0.57; protein levels in BALF: 134 [+ or -] 22 vs 442 [+ or -] 99 vs 225 [+ or -] 41 vs 337 [+ or -] 53, all P < 0.05). Compared to the CPB treatment, ECFCs significantly improved pulmonary capillary permeability and PaO.sub.2/FiO.sub.2. Similarly, ECFCs also decreased the inflammatory cell number and pro-inflammatory factors in BALF and peripheral blood, as well as the oxidative stress response in the lung tissue. ECFCs reduced the lung histological injury score and apoptosis and regulated apoptosis-related proteins in the lung tissue. Compared with the CPB/ECFC group, all the indicators were partly reversed by the L-NIO. ECFCs significantly reduced lung injury induced by inflammation after CPB. Abstract Background Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect of endothelial colony-forming cells (ECFCs) on lung injury in rats subjected to CPB. Methods Thirty-two rats were randomized into the sham, CPB, CPB/ECFC and CPB/ECFC/L-NIO groups. The rats in the sham group received anaesthesia, and the rats in the other groups received CPB. The rats also received PBS, ECFCs and L-NIO-pre-treated ECFCs. After 24 h of CPB, pulmonary capillary permeability, including the PaO2/FiO2 ratio, protein levels in bronchoalveolar lavage fluid (BALF) and lung tissue wet/dry weight were evaluated. The cell numbers and cytokines in BALF and peripheral blood were tested. Endothelial injury, lung histological injury and apoptosis were assessed. The oxidative stress response and apoptosis-related proteins were analysed. Results After CPB, all the data deteriorated compared with those obtained in the S group (sham vs CPB vs CPB/ECFC vs CPB/ECFC/L-NIO: histological score 1.62 ± 0.51 vs 5.37 ± 0.91 vs 3.37 ± 0.89 vs 4.37 ± 0.74; PaO2/FiO2 389 ± 12 vs 233 ± 36 vs 338 ± 28 vs 287 ± 30; wet/dry weight 3.11 ± 0.32 vs 6.71 ± 0.73 vs 4.66 ± 0.55 vs 5.52 ± 0.57; protein levels in BALF: 134 ± 22 vs 442 ± 99 vs 225 ± 41 vs 337 ± 53, all P < 0.05). Compared to the CPB treatment, ECFCs significantly improved pulmonary capillary permeability and PaO2/FiO2. Similarly, ECFCs also decreased the inflammatory cell number and pro-inflammatory factors in BALF and peripheral blood, as well as the oxidative stress response in the lung tissue. ECFCs reduced the lung histological injury score and apoptosis and regulated apoptosis-related proteins in the lung tissue. Compared with the CPB/ECFC group, all the indicators were partly reversed by the L-NIO. Conclusions ECFCs significantly reduced lung injury induced by inflammation after CPB. Background Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect of endothelial colony-forming cells (ECFCs) on lung injury in rats subjected to CPB. Methods Thirty-two rats were randomized into the sham, CPB, CPB/ECFC and CPB/ECFC/L-NIO groups. The rats in the sham group received anaesthesia, and the rats in the other groups received CPB. The rats also received PBS, ECFCs and L-NIO-pre-treated ECFCs. After 24 h of CPB, pulmonary capillary permeability, including the PaO2/FiO2 ratio, protein levels in bronchoalveolar lavage fluid (BALF) and lung tissue wet/dry weight were evaluated. The cell numbers and cytokines in BALF and peripheral blood were tested. Endothelial injury, lung histological injury and apoptosis were assessed. The oxidative stress response and apoptosis-related proteins were analysed. Results After CPB, all the data deteriorated compared with those obtained in the S group (sham vs CPB vs CPB/ECFC vs CPB/ECFC/L-NIO: histological score 1.62 ± 0.51 vs 5.37 ± 0.91 vs 3.37 ± 0.89 vs 4.37 ± 0.74; PaO2/FiO2 389 ± 12 vs 233 ± 36 vs 338 ± 28 vs 287 ± 30; wet/dry weight 3.11 ± 0.32 vs 6.71 ± 0.73 vs 4.66 ± 0.55 vs 5.52 ± 0.57; protein levels in BALF: 134 ± 22 vs 442 ± 99 vs 225 ± 41 vs 337 ± 53, all P < 0.05). Compared to the CPB treatment, ECFCs significantly improved pulmonary capillary permeability and PaO2/FiO2. Similarly, ECFCs also decreased the inflammatory cell number and pro-inflammatory factors in BALF and peripheral blood, as well as the oxidative stress response in the lung tissue. ECFCs reduced the lung histological injury score and apoptosis and regulated apoptosis-related proteins in the lung tissue. Compared with the CPB/ECFC group, all the indicators were partly reversed by the L-NIO. Conclusions ECFCs significantly reduced lung injury induced by inflammation after CPB. |
ArticleNumber | 246 |
Audience | Academic |
Author | Ju, Yingnan Sun, Haibin Xu, Guangxiao Zhao, Xiaoqing Tai, Qihang Gao, Wei |
Author_xml | – sequence: 1 fullname: Sun, Haibin – sequence: 2 fullname: Zhao, Xiaoqing – sequence: 3 fullname: Tai, Qihang – sequence: 4 fullname: Xu, Guangxiao – sequence: 5 fullname: Ju, Yingnan – sequence: 6 fullname: Gao, Wei |
BookMark | eNptkl1rFDEYhQep2Fr7B7waEAQvpiaZycfcCKW0daEgaO9DPnezZJI1yYj77007RTtgcpFw8rwnb8J525yEGEzTvIfgEkJGPmfYI0Y7gEAHIEWoo6-aM0gx7QiG6OTF_rS5yHkP6uh7AMjwpjntEWakJ_iskTdBx7Iz3gnfquhjOHY2psmFbauM97lNRs_K6LZCrZ-r7MJ-Tse6LLo8tkok7eJh9lMMoh7J40HkXIk2iZLfNa-t8NlcPK_nzcPtzcP11-7-293m-uq-U5ii0hGgqCYDGJBmdJBKWmZGZnpp9KgJwlAQPI4WSDBKNAIoqBVoRART1ktp-_Nms9jqKPb8kNxUW-FROP4kxLTlIhWnvOEM1mvqtJjpYTSUKSwxppopavFIH72-LF6HWU5GKxNKEn5luj4Jbse38RenPWQDxdXgw7NBij9nkwvfxzmF-nyOBjRQMlJK_1FbUbtywcZqpiaXFb8iiAGIh6Gv1OV_qDq1mZyqqbCu6quCT6uCyhTzu2zFnDPf_Pi-Zj--YHdG-LLL0c_FxZDXIFpAlWLOydi_vwEBf0wkXxLJayL5UyLrZ_wBftjRjg |
CitedBy_id | crossref_primary_10_2147_JIR_S365970 crossref_primary_10_3389_fcvm_2022_1000761 crossref_primary_10_1186_s12872_023_03664_3 crossref_primary_10_1186_s13287_021_02567_4 crossref_primary_10_1080_14779072_2022_2149492 crossref_primary_10_1186_s12872_024_03909_9 |
Cites_doi | 10.1053/j.jvca.2005.02.002 10.1097/01.shk.0000235137.13152.44 10.1016/j.jtcvs.2018.09.017 10.1152/ajplung.00380.2006 10.1016/j.arcmed.2018.08.006 10.1016/j.bbrc.2010.06.108 10.1136/thx.2010.135996 10.1016/j.jtcvs.2018.08.092 10.1152/ajplung.00442.2009 10.1097/MOT.0b013e32833454b5 10.1016/S0003-4975(00)01474-0 10.1097/00003246-199711000-00021 10.1177/1535370214542072 10.1002/jcb.25492 10.1016/j.brainres.2014.09.077 10.1111/j.1540-8191.2009.00823.x 10.1097/ALN.0b013e3182567f84 10.1016/j.ijcard.2010.04.018 10.1186/2040-2384-2-6 10.1002/jbm.a.30907 10.1067/mtc.2002.121977 10.1016/j.ajpath.2015.04.010 10.1016/j.jtcvs.2008.11.014 10.1093/icvts/ivu270 10.2174/1381612033391405 10.1016/j.jacc.2007.09.059 10.1186/1465-9921-8-50 10.1164/ajrccm.161.3.9905003 10.1016/j.healun.2005.02.013 10.1097/ALN.0b013e3181733115 10.1111/jocs.12264 10.1586/14737140.3.4.563 10.1016/j.jtcvs.2017.05.051 10.1165/rcmb.2003-0034OC 10.1016/S0003-4975(01)02637-6 10.1038/s41598-017-17561-1 10.1378/chest.117.4.1162 10.1371/journal.pone.0189501 10.3892/ijmm.2012.1180 10.1016/j.jcrc.2015.04.125 10.1182/blood-2006-08-043471 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 |
DBID | AAYXX CITATION ISR 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PIMPY PQEST PQQKQ PQUKI PRINS 5PM DOA |
DOI | 10.1186/s13287-020-01722-7 |
DatabaseName | CrossRef Gale in Context: Science ProQuest Central (Corporate) Health & Medicine (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1757-6512 |
EndPage | 12 |
ExternalDocumentID | oai_doaj_org_article_81404040f58d49e78c5b557d8c7f597f A628015443 10_1186_s13287_020_01722_7 |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: ; grantid: ¥180,000 – fundername: ; grantid: ¥100,000 |
GroupedDBID | --- -56 -5G -BR 0R~ 3V. 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAYXX ABDBF ABUWG ACGFS ACIHN ACJQM ACPRK ACRMQ ADBBV ADINQ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C24 C6C CCPQU CITATION DIK E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR IHW INH INR ISR ITC KQ8 LK8 M1P M7P M~E O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SBL SOJ SV3 TUS UKHRP AFGXO 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-c572t-60c7d64042d874bcbf8e98e3bed9d6251a6599f0b09b2901a7fa29265783bbf3 |
IEDL.DBID | RPM |
ISSN | 1757-6512 |
IngestDate | Tue Oct 22 15:09:56 EDT 2024 Tue Sep 17 21:18:46 EDT 2024 Thu Oct 10 17:23:41 EDT 2024 Tue Nov 19 20:36:55 EST 2024 Tue Nov 12 22:41:53 EST 2024 Thu Aug 01 20:19:42 EDT 2024 Tue Aug 20 22:13:10 EDT 2024 Thu Nov 21 20:47:51 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c572t-60c7d64042d874bcbf8e98e3bed9d6251a6599f0b09b2901a7fa29265783bbf3 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318475/ |
PMID | 32586365 |
PQID | 2424769777 |
PQPubID | 2040189 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_81404040f58d49e78c5b557d8c7f597f pubmedcentral_primary_oai_pubmedcentral_nih_gov_7318475 proquest_journals_2424769777 gale_infotracmisc_A628015443 gale_infotracacademiconefile_A628015443 gale_incontextgauss_ISR_A628015443 gale_healthsolutions_A628015443 crossref_primary_10_1186_s13287_020_01722_7 |
PublicationCentury | 2000 |
PublicationDate | 2020-06-25 |
PublicationDateYYYYMMDD | 2020-06-25 |
PublicationDate_xml | – month: 06 year: 2020 text: 2020-06-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Stem cell research & therapy |
PublicationYear | 2020 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | JD Patel (1722_CR33) 2007; 80 BR Everaert (1722_CR13) 2010; 144 W Gao (1722_CR14) 2019; 157 V Toprak (1722_CR34) 2006; V20N1 C Schlensak (1722_CR4) 2002; 123 BJ Oh (1722_CR9) 2010; 398 S Hirao (1722_CR16) 2017; 154 PJ Yu (1722_CR28) 2013; 710 TM Egan (1722_CR37) 2006; 25 E Apostolakis (1722_CR6) 2010; 25 M Fu (1722_CR12) 2015; 308 JL Rossi (1722_CR30) 2007; 292 CM Kahler (1722_CR18) 2007; 8 D Burger (1722_CR11) 2015; 185 1722_CR35 C Schlensak (1722_CR31) 2000; 70 J Qiu (1722_CR43) 2013; 31 H Imura (1722_CR5) 2009; 137 I Slottosch (1722_CR20) 2014; 19 JP Cao (1722_CR25) 2012; 116 PF Cartron (1722_CR42) 2003; 3 DP Sieveking (1722_CR15) 2008; 51 MC Yoder (1722_CR7) 2007; 109 A Paunel-Gorgulu (1722_CR23) 2017; 7 PJ Critser (1722_CR8) 2010; 15 YN Ju (1722_CR10) 2018; 49 MY Rady (1722_CR2) 1997; 25 XC Bao (1722_CR36) 2018; 314 A Kogan (1722_CR3) 2014; 29 M Kawashima (1722_CR38) 2000; 161 RS Stephens (1722_CR39) 2010; 299 V Siavashi (1722_CR19) 2016; 117 W Gao (1722_CR22) 2014; 239 W Gao (1722_CR21) 2019; 157 S Li (1722_CR26) 2014; 1593 SM Opal (1722_CR27) 2000; 117 U Goebel (1722_CR40) 2008; 108 RR Bartz (1722_CR1) 2015; 30 CA Owen (1722_CR24) 2003; 29 Y Hayashi (1722_CR32) 2001; 72 HC Muller (1722_CR29) 2010; 65 A Siddique (1722_CR44) 2010; 2 X Zhou (1722_CR17) 2017; 12 J Rivo (1722_CR41) 2007; 27 |
References_xml | – volume: V20N1 start-page: 63 year: 2006 ident: 1722_CR34 publication-title: J Cardiothorac Vasc Anesth doi: 10.1053/j.jvca.2005.02.002 contributor: fullname: V Toprak – volume: 27 start-page: 266 issue: 3 year: 2007 ident: 1722_CR41 publication-title: Shock doi: 10.1097/01.shk.0000235137.13152.44 contributor: fullname: J Rivo – volume: 157 start-page: 272 issue: 1 year: 2019 ident: 1722_CR21 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2018.09.017 contributor: fullname: W Gao – volume: 292 start-page: L1327 issue: 6 year: 2007 ident: 1722_CR30 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00380.2006 contributor: fullname: JL Rossi – volume: 49 start-page: 172 issue: 3 year: 2018 ident: 1722_CR10 publication-title: Arch Med Res doi: 10.1016/j.arcmed.2018.08.006 contributor: fullname: YN Ju – volume: 398 start-page: 627 issue: 4 year: 2010 ident: 1722_CR9 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2010.06.108 contributor: fullname: BJ Oh – volume: 65 start-page: 1077 issue: 12 year: 2010 ident: 1722_CR29 publication-title: Thorax doi: 10.1136/thx.2010.135996 contributor: fullname: HC Muller – volume: 157 start-page: 803 issue: 2 year: 2019 ident: 1722_CR14 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2018.08.092 contributor: fullname: W Gao – volume: 299 start-page: L323 issue: 3 year: 2010 ident: 1722_CR39 publication-title: Am J Physiol Lung Cell Mol Physiol. doi: 10.1152/ajplung.00442.2009 contributor: fullname: RS Stephens – volume: 15 start-page: 68 issue: 1 year: 2010 ident: 1722_CR8 publication-title: Curr Opin Organ Transplant doi: 10.1097/MOT.0b013e32833454b5 contributor: fullname: PJ Critser – volume: 70 start-page: 337 year: 2000 ident: 1722_CR31 publication-title: Ann Thorac Surg doi: 10.1016/S0003-4975(00)01474-0 contributor: fullname: C Schlensak – volume: 25 start-page: 1831 issue: 11 year: 1997 ident: 1722_CR2 publication-title: Crit Care Med doi: 10.1097/00003246-199711000-00021 contributor: fullname: MY Rady – volume: 239 start-page: 1597 issue: 12 year: 2014 ident: 1722_CR22 publication-title: Exp Biol Med doi: 10.1177/1535370214542072 contributor: fullname: W Gao – volume: 117 start-page: 1934 issue: 8 year: 2016 ident: 1722_CR19 publication-title: J Cell Biochem doi: 10.1002/jcb.25492 contributor: fullname: V Siavashi – volume: 1593 start-page: 65 year: 2014 ident: 1722_CR26 publication-title: Brain Res doi: 10.1016/j.brainres.2014.09.077 contributor: fullname: S Li – volume: 25 start-page: 47 issue: 1 year: 2010 ident: 1722_CR6 publication-title: J Card Surg doi: 10.1111/j.1540-8191.2009.00823.x contributor: fullname: E Apostolakis – volume: 116 start-page: 1278 issue: 6 year: 2012 ident: 1722_CR25 publication-title: Anesthesiology doi: 10.1097/ALN.0b013e3182567f84 contributor: fullname: JP Cao – volume: 144 start-page: 350 issue: 3 year: 2010 ident: 1722_CR13 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2010.04.018 contributor: fullname: BR Everaert – volume: 308 start-page: H11 issue: 1 year: 2015 ident: 1722_CR12 publication-title: Am J Phys Heart Circ Phys contributor: fullname: M Fu – volume: 2 start-page: 6 year: 2010 ident: 1722_CR44 publication-title: J Angiogenes Res doi: 10.1186/2040-2384-2-6 contributor: fullname: A Siddique – volume: 80 start-page: 381 issue: 2 year: 2007 ident: 1722_CR33 publication-title: J Biomed Mater Res A doi: 10.1002/jbm.a.30907 contributor: fullname: JD Patel – volume: 123 start-page: 1199 issue: 6 year: 2002 ident: 1722_CR4 publication-title: J Thorac Cardiovasc Surg doi: 10.1067/mtc.2002.121977 contributor: fullname: C Schlensak – volume: 185 start-page: 2309 issue: 8 year: 2015 ident: 1722_CR11 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2015.04.010 contributor: fullname: D Burger – volume: 137 start-page: 1530 issue: 6 year: 2009 ident: 1722_CR5 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2008.11.014 contributor: fullname: H Imura – volume: 19 start-page: 962 issue: 6 year: 2014 ident: 1722_CR20 publication-title: Interact Cardiovasc Thorac Surg doi: 10.1093/icvts/ivu270 contributor: fullname: I Slottosch – ident: 1722_CR35 doi: 10.2174/1381612033391405 – volume: 51 start-page: 660 issue: 6 year: 2008 ident: 1722_CR15 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.09.059 contributor: fullname: DP Sieveking – volume: 8 start-page: 50 year: 2007 ident: 1722_CR18 publication-title: Respir Res doi: 10.1186/1465-9921-8-50 contributor: fullname: CM Kahler – volume: 161 start-page: 935 year: 2000 ident: 1722_CR38 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.161.3.9905003 contributor: fullname: M Kawashima – volume: 25 start-page: 110 year: 2006 ident: 1722_CR37 publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2005.02.013 contributor: fullname: TM Egan – volume: 314 start-page: L287 issue: 2 year: 2018 ident: 1722_CR36 publication-title: Am J Physiol Lung Cell Mol Physiol contributor: fullname: XC Bao – volume: 108 start-page: 1025 issue: 6 year: 2008 ident: 1722_CR40 publication-title: Anesthesiology doi: 10.1097/ALN.0b013e3181733115 contributor: fullname: U Goebel – volume: 29 start-page: 41 issue: 1 year: 2014 ident: 1722_CR3 publication-title: J Card Surg doi: 10.1111/jocs.12264 contributor: fullname: A Kogan – volume: 3 start-page: 563 issue: 4 year: 2003 ident: 1722_CR42 publication-title: Expert Rev Anticancer Ther doi: 10.1586/14737140.3.4.563 contributor: fullname: PF Cartron – volume: 154 start-page: 1973 issue: 6 year: 2017 ident: 1722_CR16 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2017.05.051 contributor: fullname: S Hirao – volume: 29 start-page: 283 issue: 3 Pt 1 year: 2003 ident: 1722_CR24 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2003-0034OC contributor: fullname: CA Owen – volume: 72 start-page: 149 issue: 1 year: 2001 ident: 1722_CR32 publication-title: Ann Thorac Surg doi: 10.1016/S0003-4975(01)02637-6 contributor: fullname: Y Hayashi – volume: 7 start-page: 17421 issue: 1 year: 2017 ident: 1722_CR23 publication-title: Sci Rep doi: 10.1038/s41598-017-17561-1 contributor: fullname: A Paunel-Gorgulu – volume: 117 start-page: 1162 issue: 4 year: 2000 ident: 1722_CR27 publication-title: Chest doi: 10.1378/chest.117.4.1162 contributor: fullname: SM Opal – volume: 12 start-page: e0189501 issue: 12 year: 2017 ident: 1722_CR17 publication-title: PLoS One doi: 10.1371/journal.pone.0189501 contributor: fullname: X Zhou – volume: 31 start-page: 91 issue: 1 year: 2013 ident: 1722_CR43 publication-title: Int J Mol Med doi: 10.3892/ijmm.2012.1180 contributor: fullname: J Qiu – volume: 30 start-page: 940 issue: 5 year: 2015 ident: 1722_CR1 publication-title: J Crit Care doi: 10.1016/j.jcrc.2015.04.125 contributor: fullname: RR Bartz – volume: 109 start-page: 1801 issue: 5 year: 2007 ident: 1722_CR7 publication-title: Blood doi: 10.1182/blood-2006-08-043471 contributor: fullname: MC Yoder – volume: 710 start-page: 39 issue: 1–3 year: 2013 ident: 1722_CR28 publication-title: Eur J Pharmacol contributor: fullname: PJ Yu |
SSID | ssj0000330064 |
Score | 2.3098073 |
Snippet | Background Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect... Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate the effect of... Abstract Background Cardiopulmonary bypass (CPB) results in severe lung injury via inflammation and endothelial injury. The aim of this study was to evaluate... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 1 |
SubjectTerms | Alveoli Anesthesia Apoptosis Bronchus Cardiopulmonary bypass Catheters Cell number Colonies Colony-forming cells Coronary artery bypass Cytokines Endothelial colony-forming cells Endothelium Experiments Heart surgery Inflammation Laboratory animals Lung injury Lungs Medical research Membrane permeability Microscopy Oxidative stress Peripheral blood Permeability Proteins Rodents Studies Veins & arteries Ventilation |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagEhIXxFNsKdRCSByQ1dQbv46FbkUvPdAeuFkeP6Bola6a7mH_PTNOdtXAgQvKIVI8iuJ5z67nG8Y-GEALK00jCB1cECKXCCCdAGeOlQ0asqpDbC_NxXd7uiCYnN2oLzoTNsADD4w7IkQmuoqyqXXZ2KhAKZNsNAWT4VK9b2PuFVPVB2OZjsF22yVj9VGPZRfaE1VLVPZgWjmJRBWw_2-3_OdRyXux5-wpezImjfxk-Nhn7EHunrNHwxjJzQsGiy5RI9USdYkTCnW3EZSLYlTi9MN8z28JoDUnjkR8iebNr7tfyEy8Dc9hw2M9mLpaL1EvAy7BZoV5NVJw1JH-Jbs6W1x9-SrG2QkiKiPvhG6iSRoZJ5M1LUQoNjub55CTS1jzHAetnCsNNA7or9RgSpBOajTgOUCZv2J73U2XXzMujSqptaWVssFI5iAHsODakqLO-M4Z-7Rlo18NCBm-VhZW-4HpHpnuK9O9mbHPxOkdJaFb1wcocz_K3P9L5jN2SHLyQ6vozkb9iZa2TlWbz9j7SkEIFx0dofkR1n3vzy-_TYg-jkTlBoUbw9iRgPsmUKwJ5cGEEk0wTpe3CuNHF9B76rsxGtNr3LOZKNFk89OV7vpnhfg26Gpbo_b_B7fesMeyqr0WUh2wvbvbdX7LHvZp_a4azW9k6Bms priority: 102 providerName: Directory of Open Access Journals |
Title | Endothelial colony-forming cells reduced the lung injury induced by cardiopulmonary bypass in rats |
URI | https://www.proquest.com/docview/2424769777 https://pubmed.ncbi.nlm.nih.gov/PMC7318475 https://doaj.org/article/81404040f58d49e78c5b557d8c7f597f |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF7iQEsupU_qNE2XUuihKFZW2tcxSR2aQ0tJcii9LNpX4uDIxooP_vedWUnBam_FYIN2LLyz3-zMyDPfEvJJWrCwmOcZsoNnyMiVVZbpzGp5zFUlbODpENsr-eOX-jpFmhze98Kkon1nZ0f1_P6ont2m2srlvZv0dWKTn9_PJACxlHwyIiOIDbdS9LT9QoYOfrZvkFFi0kDGBaaEiRJmPBBR7pGnBeNKFOhTtvxRou3_d3P-u2ByywOdPyfPutCRnrQ_8QXZCfVL8qQ9THLzithp7bGdag6IoshFXW8yjEjBN1F8PN_QFdK0Bk9BiM7ByOmsvgOVwkd73W6oS-Wpy_Uc0FnBkN0sIboGCQpIaV6T6_Pp9dm3rDtBIXNcsodM5E56UYJheiVL62xUQatQ2OC1h8znuBJc65jbXFv8Q7WSsWKaCTDjwtpYvCG79aIObwllkkdfqlgyloM_0zZUVlldRu9EgHuOyZdejWbZ8mSYlF8oYVr9G9C_Sfo3ckxOUdOPkshxnS4sVjemW2mDXFz4ilz5UgepHLecS6-cjJAGxTH5gOtk2obRR0s1J4KpdLZaMSYfkwTyXNRYSHNTrZvGXFxdDoQ-d0JxAYvrqq4vAeaN1FgDyYOBJBiiGw73gDHdRtAY7L6RAoJsmLMcgGgw-eEI4D4RfXc43__vb74jeyzBXmSMH5Ddh9U6vCejxq8P08MHeL88_X2YDOgPAhEdBQ |
link.rule.ids | 230,315,729,782,786,866,887,2107,27934,27935,53802,53804 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RIqAXnkUECl0hJA7Ijbv2vo6lpGpFWyGaA7eV91WCUieKm0P-PTNrp4rhVuUQyTuJvJ5vXsnMt4R8khYsLOZ5huzgGTJyZZVlOrNaHnJVCRt4OsT2Sl7-Ut9GSJPD17MwqWnf2clBPb05qCe_U2_l_MYN131iwx8XxxKAWEo-3CIPwV5ztlGkJwcMNTpE2vWIjBLDBmouMCYslbDmgZxyhzwuGFeiwKiyEZEScf__7vnflsmNGHTy7J53_5w87ZJOetQuvyAPQv2SPGqPoVy9InZUexzEmgIWKbJY16sMc1mIahR_2G_oAgleg6cgRKfgHuik_gPKgLf2ul1Rlxpb58sp4LqCJbuaQ14OEhQw1uyS8clofHyadWcvZI5LdpuJ3EkvSjBpr2RpnY0qaBUKG7z2UDMdVoJrHXOba4t_xVYyVkwzAQ6gsDYWr8l2PavDG0KZ5NGXKpaM5RAJtQ2VVVaX0TsR4DsH5Mv68Zt5y7BhUmWihGn1ZkBvJunNyAH5ihq6k0R27HRhtrg23VM2yOKFr8iVL3WQynHLufTKyQgFVByQfdSvaUdN72zcHAmm0qlsxYB8TBLIkFFjC851tWwac3b1syf0uROKMwCFq7qJBtg3kmr1JPd6kmDCrr-8BprpXEhjcG5HCkjPYc-yB77e5vsrgLlEEd5h7O29P7lPnpyOL87N-dnl93dkhyXTERnje2T7drEM78lW45cfkuH9BXrSMI4 |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF7RIqpeeCMChVoIiQNy7a69r2NpE1EBVUV74LbyvkpQ6lhxc8i_Z2btRDHcQD5Y8o4tredtz3xDyHthQMNCnqeIDp4iIldaGapSo8QxkxU3nsUhtlfi4oc8GyNMzmbUVyzat2Z6VM9uj-rpz1hb2dzabF0nll1-OxUgiKVgWeNCtkPug87m5VaiHo0w5OngbddtMpJnLeRdoFCYLmHeA3HlPtkrKJO8QM-y5ZUieP_fJvrPssktPzR59B87eEwe9sFnctKRPCH3fP2UPOjGUa6eETOuHTZkzUAmE0SzrlcpxrTg3RL8wN8mCwR69S4BomQGZiKZ1r-AKXDqrptVYmOBa7OcgXxXsGRWDcTnQJGArLXPyfVkfH36Oe1nMKSWCXqX8twKx0tQbSdFaawJ0ivpC-OdcpA7HVecKRVykyuDv2QrESqqKAdDUBgTihdkt57X_iVJqGDBlTKUlObgEZXxlZFGlcFZ7uGZI_JxzQLddEgbOmYokuuOdxp4pyPvtBiRT8ilDSWiZMcL88WN7t-0RjQvPAKTrlReSMsMY8JJKwIkUmFEDpHHums53ei6PuFUxulsxYi8ixSIlFFjKc5NtWxbfX71fUD0oScKcxAMW_WdDbBvBNcaUB4MKEGV7XB5LWy6NyWtxv4dwSFMhz2LgQAONj9cAbmLUOG9nL365zsPyd7l2UR_Pb_48prs06g9PKXsgOzeLZb-Ddlp3fJt1L3fBtUzDg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endothelial+colony-forming+cells+reduced+the+lung+injury+induced+by+cardiopulmonary+bypass+in+rats&rft.jtitle=Stem+cell+research+%26+therapy&rft.au=Sun%2C+Haibin&rft.au=Zhao%2C+Xiaoqing&rft.au=Tai%2C+Qihang&rft.au=Xu%2C+Guangxiao&rft.date=2020-06-25&rft.pub=BioMed+Central&rft.eissn=1757-6512&rft.volume=11&rft.spage=1&rft_id=info:doi/10.1186%2Fs13287-020-01722-7 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-6512&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-6512&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-6512&client=summon |